Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE): Quality and safety in the implementation of medicinal cannabis use in the community

澳大利亚大麻素临床和研究卓越中心 (ACRE)：社区药用大麻使用的质量和安全性

• 批准号: nhmrc : GNT1135054
• 负责人: Dr Amirali Popat
• 金额: $ 249.85万
• 依托单位国家: 澳大利亚
• 项目类别: Centres of Research Excellence
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/australian-centre-cannabinoid-use-community/1347973
• 关键词: Australian; Centre; Cannabinoid; Clinical; Research

Australia has a world-first opportunity to develop rigorous medical cannabis research based on quality clinical and environmental science that tests and selects cannabis constituents affecting health and sickness. It will be able to design and coordinate dose and formulation-finding studies to assess safety and efficacy of different cannabinoids. This information will enable registration of products for health that have been thoroughly researched and tested to levels acceptable for public use.

澳大利亚有世界第一的机会，基于优质的临床和环境科学开发严格的医用大麻研究，该研究测试并选择影响健康和疾病的大麻成分。它将能够设计和协调剂量和配方调查研究，以评估不同大麻素的安全性和功效。该信息将使对健康的产品进行注册，这些产品已经过彻底研究并测试到可接受的公共用途水平。